Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other Non-Current Assets (2020 - 2025)

Oncology Institute's Other Non-Current Assets history spans 6 years, with the latest figure at $606000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 2.89% year-over-year to $606000.0; the TTM value through Dec 2025 reached $606000.0, up 2.89%, while the annual FY2025 figure was $606000.0, 2.89% up from the prior year.
  • Other Non-Current Assets reached $606000.0 in Q4 2025 per TOI's latest filing, up from $586000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $875000.0 in Q1 2022 to a low of $320000.0 in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $564625.0, with a median of $575000.0 recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 162.3% in 2021, then tumbled 39.77% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $320000.0 in 2021, then skyrocketed by 49.06% to $477000.0 in 2022, then increased by 17.61% to $561000.0 in 2023, then increased by 4.99% to $589000.0 in 2024, then grew by 2.89% to $606000.0 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Other Non-Current Assets are $606000.0 (Q4 2025), $586000.0 (Q3 2025), and $586000.0 (Q2 2025).